HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: Seroprevalence and risk factors

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 2, 2001, Pages 185-190

  Etzel, Arnaldo ^a   Shibata, Gicelene Y ^a   Rozman, Mauro ^b   Jorge, Maria Lucia S G ^c   Damas, Cristine D ^c   Segurado, Aluisio A C ^c,d  

^a AIDS Reference Center   (Brazil)

^b AIDS Reference and Training Center   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

Brazil; HIV; HTLV 1; HTLV 2; Risk factors; Seroprevalence

Indexed keywords

ARTICLE; BRAZIL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; PROSTITUTION; REGRESSION ANALYSIS; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

EID: 0035251417     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200102010-00015     Document Type: Article

References (30)

1. Structure and classification of retroviruses
2. Human lymphotropic viruses: HTLV-1 and HTLV-2
3. Worldwide distribution of HTLV
4. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as means of monitoring viral transmission and movement of ancient human populations
5. Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama
6. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama
7. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian amerindians
8. HTLV-II among pygmies from Cameron
9. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region
10. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil - Impact on markers of HIV disease progression
11. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil
12. HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users
13. Retroviral coinfections at a New Orleans HIV outpatient clinic
14. De capital da AIDS a porto da esperança
15. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II
16. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotrupic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins
17. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil
18. Laboratory characterization of human T-cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil
19. Distribution of human T-lymphotropic virus type I among blood donors: A nationwide Brazilian study
20. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection
21. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil
22. Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica
23. Endemic transmission of HTLV type II among Kayapo Indians of Brazil
24. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among U.S. intravenous drug users
25. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica
26. Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad
27. HIV/HTLV-I coinfection and clinical grade at diagnosis
28. Characterization of hepatitis C replication in cloned cells obtained from a human T-cell leukemia virus type I-infected cell line, MT-2
29. Human T-cell lymphotropic virus-I coinfection in patients with chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus